Financial results - DR. BALDEA & DR. BALDEA SRL

Financial Summary - Dr. Baldea & Dr. Baldea Srl
Unique identification code: 22605623
Registration number: J08/2840/2007
Nace: 8622
Sales - Ron
60.153
Net Profit - Ron
40.989
Employee
1
The most important financial indicators for the company Dr. Baldea & Dr. Baldea Srl - Unique Identification Number 22605623: sales in 2023 was 60.153 euro, registering a net profit of 40.989 euro and having an average number of 1 employees. Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Dr. Baldea & Dr. Baldea Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 2.292 2.452 14.319 29.672 30.951 29.259 27.746 36.027 44.693 60.153
Total Income - EUR 2.292 2.452 14.319 29.672 30.951 29.259 27.746 36.041 45.316 61.011
Total Expenses - EUR 2.342 2.593 7.430 13.101 12.713 13.635 12.160 11.178 12.530 19.425
Gross Profit/Loss - EUR -50 -141 6.890 16.571 18.238 15.624 15.586 24.864 32.786 41.587
Net Profit/Loss - EUR -119 -214 6.556 16.274 17.928 15.331 15.119 24.510 32.342 40.989
Employees 1 1 1 2 1 1 1 1 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 35.0%, from 44.693 euro in the year 2022, to 60.153 euro in 2023. The Net Profit increased by 8.745 euro, from 32.342 euro in 2022, to 40.989 in the last year.

Check the financial reports for the company - Dr. Baldea & Dr. Baldea Srl

Rating financiar

Financial Rating -
Dr. Baldea & Dr. Baldea Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Dr. Baldea & Dr. Baldea Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Dr. Baldea & Dr. Baldea Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Dr. Baldea & Dr. Baldea Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Dr. Baldea & Dr. Baldea Srl - CUI 22605623

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 0 0 0 0 2.728 1.807 997 609 905 1.296
Current Assets 436 372 7.063 17.028 18.054 15.103 14.806 24.605 34.105 42.137
Inventories 0 0 0 0 0 0 0 0 247 0
Receivables 169 0 1.444 2.512 2.536 332 0 0 24.655 5.139
Cash 267 372 5.619 14.516 15.518 14.771 14.806 24.605 9.202 36.998
Shareholders Funds 280 68 6.623 16.327 17.980 15.382 15.168 24.559 32.391 41.037
Social Capital 45 45 45 44 43 42 41 40 41 40
Debts 156 305 440 701 2.801 1.528 634 656 2.619 2.396
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 42.137 euro in 2023 which includes Inventories of 0 euro, Receivables of 5.139 euro and cash availability of 36.998 euro.
The company's Equity was valued at 41.037 euro, while total Liabilities amounted to 2.396 euro. Equity increased by 8.745 euro, from 32.391 euro in 2022, to 41.037 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Dr. Baldea & Dr. Baldea Srl

Comments - Dr. Baldea & Dr. Baldea Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.